A putative class action in federal court in Newark alleges the maker of Excedrin Migraine is duping customers by charging a higher price for a medicine identical to a lower-priced line.
January 03, 2014 at 06:22 PM
1 minute read
A putative class action in federal court in Newark alleges the maker of Excedrin Migraine is duping customers by charging a higher price for a medicine identical to a lower-priced line.
Novartis Corp., of East Hanover, N.J., sells Excedrin Migraine at a wholesale price of $3.60 for 24 tablets, which is 12.5 percent more than for its $3.20 priced Excedrin Extra Strength.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
